Loading
JP
Juniper Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by GERAGHTY JAMES A, was filed 20 Mar 2017.
Juniper Pharmaceuticals Inc: what insiders have been doing
Juniper Pharmaceuticals Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). Juniper Pharmaceuticals Inc has had no insider filing for more than a year; the last one goes back to 15 August 2018.
The full history, which starts in 2006, counts 34 purchases against 12 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
183
Thresholds
n/a
Buy Volume
€1M
34 ops. · all time
Sell Volume
€14M
12 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Revenue44.6M
Gross profit18.7M42% margin
Net income-1.8M-4.1% margin
Last declaration on 15 August 2018
Declarations183 total
13,657 shares@ US$11.506.1% of flowCommon StockSEC:0001209191-18-046792:0
250 shares@ US$11.500.1% of flowCommon StockSEC:0001209191-18-046792:1
8,000 shares@ US$11.503.6% of flowCommon StockSEC:0001209191-18-046792:4
9,700 shares@ US$11.504.3% of flowCommon StockSEC:0001209191-18-046792:5
41,000 shares@ US$11.5018.3% of flowCommon StockSEC:0001209191-18-046792:6
14,500 shares@ US$11.506.5% of flowCommon StockSEC:0001209191-18-046792:7
2,001 shares@ US$11.500.9% of flowCommon StockSEC:0001209191-18-046792:8
28,000 shares@ US$11.5012.5% of flowCommon StockSEC:0001209191-18-046792:9
6,250 shares@ US$11.502.8% of flowCommon StockSEC:0001209191-18-046792:10
875 shares@ US$11.500.4% of flowCommon StockSEC:0001209191-18-046792:11
100,000 shares@ US$11.5044.6% of flowCommon StockSEC:0001209191-18-046792:12
30,413 shares@ US$11.5096.3% of flowCommon StockSEC:0001209191-18-046773:0
16,244 shares@ US$11.50100.0% of flowCommon StockSEC:0001209191-18-046798:0
103,855 shares@ US$11.5096.6% of flowCommon StockSEC:0001209191-18-046782:0
40,000 shares@ US$7.9010.6% of flowCommon StockSEC:0001209191-18-046788:0
10,000 shares@ US$4.051.4% of flowCommon StockSEC:0001209191-18-046788:1
53,000 shares@ US$5.159.2% of flowCommon StockSEC:0001209191-18-046788:2
50,000 shares@ US$7.8213.2% of flowCommon StockSEC:0001209191-18-046788:3
32,000 shares@ US$5.566.0% of flowCommon StockSEC:0001209191-18-046788:4
32,000 shares@ US$7.057.6% of flowCommon StockSEC:0001209191-18-046788:5
123,823 shares@ US$11.5048.0% of flowCommon StockSEC:0001209191-18-046788:6
10,500 shares@ US$11.504.1% of flowCommon StockSEC:0001209191-18-046788:7
36,109 shares@ US$11.50100.0% of flowCommon StockSEC:0001209191-18-046804:0
15,000 shares@ US$11.50100.0% of flowCommon StockSEC:0001209191-18-046802:0
80,747 shares@ US$11.50100.0% of flowCommon StockSEC:0001209191-18-046810:0
25 of 183 declarations
About Juniper Pharmaceuticals Inc
Juniper Pharmaceuticals Inc is a company focused on developing pharmaceutical treatments. It concentrates on innovative solutions for unmet medical needs.
